76 related articles for article (PubMed ID: 11374801)
1. Immunohistochemical evaluation of cathepsin D expression in colorectal cancer.
Chabowski A; Sulkowska M; Sulkowski M; Famulski W; Skrzydlewska E; Kisielewski W
Folia Histochem Cytobiol; 2001; 39(2):153-4. PubMed ID: 11374801
[TBL] [Abstract][Full Text] [Related]
2. Cathepsin D activity in colorectal cancer.
Chabowski A; Skrzydlewska E; Sulkowska M; Famulski W; Zalewski B; Gnojnicki I; Kisielewski W
Rocz Akad Med Bialymst; 2001; 46():38-46. PubMed ID: 11780577
[TBL] [Abstract][Full Text] [Related]
3. [The activity of cathepsin B in colorectal adenocarcinomas].
Chabowski A; Skrzydlewska E; Sulkowska M; Famulski W; Sulkowski S; Chrzanowska A
Pol Merkur Lekarski; 2001 Oct; 11(64):330-3. PubMed ID: 11770313
[TBL] [Abstract][Full Text] [Related]
4. CD44 expression in colorectal cancer. An immunohistochemical study including correlation with cathepsin D immunoreactivity and some tumour clinicopathological features.
Zalewski B; Famulski W; Sulkowska M; Sobaniec-Lotowska M; Piotrowski Z; Kisielewski W; Sulkowski S
Folia Histochem Cytobiol; 2001; 39 Suppl 2():152-3. PubMed ID: 11820582
[TBL] [Abstract][Full Text] [Related]
5. Cathepsin D expression in human colorectal cancer: relationship with tumour type and tissue differentiation grade.
Sebzda T; Saleh Y; Gburek J; Andrzejak R; Gnus J; Siewinski M; Grzebieniak Z
J Exp Ther Oncol; 2005; 5(2):145-50. PubMed ID: 16471040
[TBL] [Abstract][Full Text] [Related]
6. Tumour budding intensity in relation to cathepsin D expression and some clinicopathological features of colorectal cancer.
Famulski W; Guzińska-Ustymowicz K; Sulkowska M; Chabowski A; Zalewski B; Piotrowski Z; Stasiak-Barmuta A; Sulkowski S
Folia Histochem Cytobiol; 2001; 39 Suppl 2():171-2. PubMed ID: 11820592
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical evaluation of tissue-specific proteolytic enzymes in adenomas containing foci of early carcinoma: correlations with cathepsin D expression and other malignant features.
Kunimura T; Inagaki T; Wada M; Ushio J; Sato K; Enosawa T; Nakashima M; Kato H; Hayashi R; Saitou K; Morohoshi T
Int J Gastrointest Cancer; 2003; 33(2-3):149-54. PubMed ID: 14716064
[TBL] [Abstract][Full Text] [Related]
8. Study of P53 protein expression in colorectal cancer.
Sulkowska M; Famulski W; Guzińska-Ustymowicz K; Sulkowski S
Folia Histochem Cytobiol; 2001; 39(2):157-8. PubMed ID: 11374803
[TBL] [Abstract][Full Text] [Related]
9. Cathepsin D expression in colorectal adenocarcinomas and adenomas.
Kanber Y; Demirbag NR; Sam AD; Aydin N
Int J Biol Markers; 2002; 17(3):165-8. PubMed ID: 12408466
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical evaluation of cathepsin D expression in colorectal tumours: a correlation with extracellular matrix components, p53, pRb, bcl-2, c-erbB-2, EGFR and proliferation indices.
Ioachim EE; Goussia AC; Machera M; Tsianos EV; Kappas AM; Agnantis NJ
Anticancer Res; 1999; 19(3A):2147-55. PubMed ID: 10470163
[TBL] [Abstract][Full Text] [Related]
11. MMP-9 and cathepsin B expression in tumor budding as an indicator of a more aggressive phenotype of colorectal cancer (CRC).
Guzińska-Ustymowicz K
Anticancer Res; 2006; 26(2B):1589-94. PubMed ID: 16619576
[TBL] [Abstract][Full Text] [Related]
12. Activity of cathepsin B and D in colorectal cancer: relationships with tumour budding.
Guzińska-Ustymowicz K; Zalewski B; Kasacka I; Piotrowski Z; Skrzydlewska E
Anticancer Res; 2004; 24(5A):2847-51. PubMed ID: 15517887
[TBL] [Abstract][Full Text] [Related]
13. Co-expression of trypsin and tumour-associated trypsin inhibitor (TATI) in colorectal adenocarcinomas.
Solakidi S; Tiniakos DG; Petraki K; Stathopoulos GP; Markaki I; Androulakis G; Sekeris CE
Histol Histopathol; 2003 Oct; 18(4):1181-8. PubMed ID: 12973686
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical evaluation of cathepsin D expression in colorectal cancer.
Mayer A; Fritz E; Fortelny R; Kofler K; Ludwig H
Cancer Invest; 1997; 15(2):106-10. PubMed ID: 9095205
[TBL] [Abstract][Full Text] [Related]
15. Activation of cathepsin B, secreted by a colorectal cancer cell line requires low pH and is mediated by cathepsin D.
van der Stappen JW; Williams AC; Maciewicz RA; Paraskeva C
Int J Cancer; 1996 Aug; 67(4):547-54. PubMed ID: 8759615
[TBL] [Abstract][Full Text] [Related]
16. The immunohistochemical expression of cathepsin D in colorectal cancer.
Valentini AM; Pirrelli M; Armentano R; Caruso ML
Anticancer Res; 1996; 16(1):77-80. PubMed ID: 8615673
[TBL] [Abstract][Full Text] [Related]
17. Cathepsin B and cathepsin D expression in the progression of colorectal adenoma to carcinoma.
Talieri M; Papadopoulou S; Scorilas A; Xynopoulos D; Arnogianaki N; Plataniotis G; Yotis J; Agnanti N
Cancer Lett; 2004 Mar; 205(1):97-106. PubMed ID: 15036666
[TBL] [Abstract][Full Text] [Related]
18. Clinical prognostic factors and expression of cathepsin D in endometrioid adenocarcinoma.
Dvalishvili I; Charkviani L; Charkviani T; Turashvili G; Burkadze G
Georgian Med News; 2005 Sep; (126):27-31. PubMed ID: 16234588
[TBL] [Abstract][Full Text] [Related]
19. Cathepsin D protein levels in colorectal tumors: divergent expression patterns suggest complex regulation and function.
Iacobuzio-Donahue C; Shuja S; Cai J; Peng P; Willett J; Murnane MJ
Int J Oncol; 2004 Mar; 24(3):473-85. PubMed ID: 14767531
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical localization of cathepsin D in colorectal tumors.
Arao J; Fukui H; Ono Y; Ueda Y; Chiba T; Fujimori T
Dis Colon Rectum; 2000 Mar; 43(3):396-401. PubMed ID: 10733123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]